APPENDIX A Certification of Advanced Disease:

Similar documents
Solid Organ Transplant Benefits to Change for Texas Medicaid

IEHP UM Subcommittee Approved Authorization Guidelines My Path (A Palliative Care Approach)

Cardiac Rehabilitation Services

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

2. The patient has a level of need that exceeds the resources of the primary palliative care provider.

Obesity/Morbid Obesity/BMI

Alzheimer s Disease, Dementia, Related Disorders

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Influenza (Flu) Fact Sheet

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes

Technical Specifications of Pediatric Ambulatory Care Sensitive Condition Hospitalizations

Objectives 2/11/2016 HOSPICE 101

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

High Performance Network Quality Criteria for Designation

COPD Outreach Program

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Through our exceptional health care services, we reveal the healing presence of God.

Through our exceptional health care services, we reveal the healing presence of God.

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead

Measure Information Form

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Nutritional Intervention Effectiveness in Oncology Patients Receiving Active Anti-Cancer Treatment: A Systematic Review

Annex III. Amendments to relevant sections of the Product Information

Related Policies None

Referral Criteria: Inflammation of the Spine Feb

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

The Financial Impact of ICD-10: Don t Let Risk Adjustment Be An Afterthought November 18, 2014

Table of Contents: Amyotrophic Lateral Sclerosis (ALS)

Chronic Fatigue Syndrome

Hospice Eligibility August 2018

o Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC)

Advantage EAP Employee Assistance Program

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Guidelines for the Admission of Children and Young People with an Eating Disorder

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

CDC Influenza Division Key Points MMWR Updates February 20, 2014

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

ICD-10-CM Coding Basics Chapter Specifics

Advance Care Planning Collaboration 101

BANKMED MEDICAL SCHEME. MEDICINE ADVISORY SERVICES (Chronic Medicine Benefit) GENERAL INFORMATION

CRITERIA FOR USE: Requires Prior Authorization by Medical Director or Designee

US Public Health Service Clinical Practice Guidelines for PrEP

Frequently Asked Questions: IS RT-Q-PCR Testing

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

DEMENTIA. DESCRIPTION: a progressive, degenerative disease of the brain, which causes impairment of thinking and memory

Top 10 Causes of Disability

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Extrapulmonary Respiratory Problems. During the First Week of Life

Folotyn (pralatrexate)

OTHER AND UNSPECIFIED DISORDERS

QUALITY AND SAFETY MEASURES UPDATE January 2016

Completing the NPA online Patient Safety Incident Report form: 2016

Pediatric Health History Form

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

ACRIN 6666 Screening Breast US Follow-up Assessment Form

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Rugby Nutrition: Achieving Body Composition Goals Practice Tips

Kentucky Medically Frail Medical Condition Guide v5 for Providers Supplement to the Kentucky Medically Frail Provider Attestation Form

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

XX Abraxane 100 MG SUSR (CELGENE CORP)

HODGKIN S LYMPHOMA (HODGKIN S DISEASE)

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

Community Health Worker / Certified Recovery Specialist Training Application

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Cognitive enhancers for the treatment of Alzheimer s disease

Ischemic heart disease (angina/chest pain)

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

Update on Concussions in Soccer

ICD-10-CM Coding Basics Chapter Specifics

Opioid Analgesics PA Request Provider Checklist

For our protection, we require verification that you have received this notice. Therefore, please sign below.

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

Understanding back pain

Memory Screening Site s PROGRAM HANDBOOK

Childhood Immunization Status (NQF 0038)

Ontario 2018 provincial election issues backgrounder

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

BRCA1 and BRCA2 Mutations

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

The data refer to persons aged between 15 and 54.

2012 Indiana Parent/Family Needs Assessment Survey

Transcription:

APPENDIX A Certificatin f Advanced Disease: Name: DOB: Member ID: Name f Palliative Care Prgram: A. General Criteria: Check each f the fllwing that apply (All needed fr eligibility). Patient wh is likely t r has started t use the hspital and/r emergency rm as a means t manage their advanced stage disease. Patient is in the advanced stage f illness with cntinued decline in health, and is nt eligible r has declined hspice. Patient has received apprpriate patient-desired medical therapy with n further traditinal therapy ptins available, is intlerant r declines further therapy, r decmpensates due t severe nn-cmpliance. Life expectancy f abut 2 years r less based n clinical status. Patients and, if applicable, family/patient-designated supprt persn agree t bth f the fllwing: a. Willing t attempt in-hme, residential-based, r utpatient disease management instead f first ging t the emergency department b. Willing t participate in Advance Care Planning (ACP) B. In additin, ne f the fllwing diagnses must be selected, and assciated severity criteria met: 1. Cngestive Heart Failure (CHF) Any patient wh is hspitalized due t CHF as the primary diagnsis. N further invasive interventins planned althugh access t curative care is maintained, NYHA III classificatin r higher (definitin f NYHA III: Patients with cardiac disease resulting in marked limitatin f physical activity. They are cmfrtable at rest. Less than rdinary activity causes fatigue, palpitatin, dyspnea r anginal pain.) ne f the fllwing: Ejectin Fractin < 30 fr systlic failure

Significant cmrbidities: e.g. renal disease, diabetes, dementia, r pr bimarkers including rising BNP, pr-bnp, hscrp, BUN/ Creatinine (patient is in their best cmpensated state), and CAD. 2. Chrnic Pulmnary Disease (e.g. COPD, Cystic Fibrsis, Pulmnary Fibrsis): Severe airflw bstructin: FEV1 < 35 % predicted 24-hur xygen dependent 3. Advanced Cancer: Any Stage III r IV cancer, lcally advanced r metastatic cancer, leukemia r lymphma ne f the fllwing: Palliative Perfrmance Scale (PPS) scre < r equal t 70% (PPS 70% = Cares fr self; unable t carry n nrmal activity r d active wrk) Failing tw lines f standard f care therapy (chemtherapy r radiatin therapy). 4. Liver Disease: Irreversible Liver Damage as evidenced by ne f the fllwing: Ascites Subacute bacterial peritnitis Hepatic encephalpathy Hepatrenal syndrme Recurrent esphageal bleeds Mdel fr End Stage Liver Disease (MELD) scre f greater than 19 T calculate MELD Scre: https://ptn.transplant.hrsa.gv/resurces/allcatin-calculatrs/meld-calculatr/ Meld Scre: 5. End Stage Renal Disease: GFR < 15

Patient refusing dialysis, has pr cmpliance, and is nt seeking renal transplant Declining status with multiple ther c-mrbidities, such as CHF, ESLD, COPD 6. Dementia: Functinal Assessment Staging Scale (FASS) scre f 5 with high risk f using the hspital t manage their disease with dcumentatin f reasn fr high risk status: FASS 6 t 7 Any demented patient wh has been institutinalized r required hspitalizatin primarily due t their dementia, plus Had an apprpriate metablic wrkup (CMP, Thyrid Functin Tests, B12) and neur imaging (r dcumented refusal) 7. Neurlgic Disease (e.g. Parkinsn s, ALS, Multiple Sclersis): Impaired breathing capacity requiring xygen Rapid disease prgressin as evidenced by decline in ambulatin status frm independent t wheelchair/ bed bund, r decline in speech t unintelligible, r decline in ral intake t pureed fds, r decline in ADLs t requiring md/max assistance Nutritinal impairment assciated with weight lss Life threatening cmplicatin event in past 12 mnths such as aspiratin pneumnia, sepsis, stage 3 r 4 pressure ulcers

8. AIDS: Palliative Perfrmance Scale (PPS) <= 50% CD4 cell cunt < 25 r viral lad >100,000 WITH either nn-cmpliance, refusal, intlerance, failure, r resistance t antiretrviral therapy Presence f ANY f the fllwing: 1. Opprtunistic infectins (e.g. multidrug-resistant M. tuberculsis, MAC, CMV, Cryptspridium, Txplasmsis, Prgressive Multifcal Leukencephalpathy) 2. AIDs related malignancy (e.g. Nn-Hdgkin s r CNS lymphma, visceral Kapsi s sarcma) 3. HIV-assciated dementia 4. HIV wasting syndrme (>10% unintentinal weight lss ver 12 mnths, 33% lss f lean bdy mass r BMI <20) 5. Declining status with presence f multiple c-mrbidities (e.g. advanced liver disease, CHF, ESRD) 9. Other advanced illness (psychiatric r substance abuse related diagnses are excluded as primary qualifying diagnses fr prgram): ICD-10: Clinical dcumentatin supprting the patient is advanced stage f disease:

C. Prgram acuity type: Lw High - requires clinical justificatin criteria includes: ACG scre = CCM level and PHU > 50% Mre than 2 inpatient admissins in the past 3 mnths Mre than 3 ER visits in the past 3 mnths Palliative Perfrmance Scale (PPSv2) 60% r less Presence f c-mrbid uncntrlled significant mental health disrder (e.g. Biplar, Schizphrenia) and marked with pr functinality (Glbal Assessment f Functining scale (GAF) <= 50) Hmeless r pr scial supprt C-mrbid active alchl and/r drug abuse Prvider Signature Date